NCT04820049已完成1 期
F573 for Injection Phase Ia Clinical Trial.
Beijing Continent Pharmaceutical Co, Ltd.1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年2月8日最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- MTD of F573 in health people
研究概览
简要总结
Tolerance and PK study of F573
详细描述
The tolerance and PK study of single dose and multi dose F573.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Placebo group
Placebo Comparator
干预措施: Placebo (Other)
F573 group
Experimental
干预措施: F573 (Drug)
结局指标
主要结局
MTD of F573 in health people
时间窗: up to 7 days
AUC of F573 in health people
时间窗: up to 7 days
Cmax of F573 in health people
时间窗: up to 7 days
Tmax of F573 in health people
时间窗: up to 7 days
t1/2 of F573 in health people
时间窗: up to 7 days
次要结局
- Number of participants with treatment-related adverse events as assessed by CTCAE v5.0(8 days)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Drug-Drug Interaction Study to Evaluate the Effect of PF-06865571 on Metformin PharmacokineticsHealthy VolunteersNCT03593707Pfizer18
已完成
1 期
Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and NeutropeniaFeverMycosesNeutropeniaNCT00001790National Cancer Institute (NCI)120
进行中（未招募）
不适用
An Efficacy and Tolerability Study of MK-0533 in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control - NDEUCTR2006-002090-47-ITMERCK SHARP DOHME100
进行中（未招募）
不适用
An Efficacy and Tolerability Study of MK-0533 in Patients with Type II Diabetes Mellitus Who Have Inadequate Glycemic Control.Type II DiabetesMedDRA version: 8.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2006-002090-47-HUMerck & Co., Inc.600
进行中（未招募）
不适用
An Efficacy and Tolerability Study of MK-0533 in Patients with Type II Diabetes Mellitus Who Have Inadequate Glycemic Control.Type II DiabetesMedDRA version: 7.1Level: LLTClassification code 10012613EUCTR2006-002090-47-DEMerck & Co. Inc.600